Newsroom

Sorted by: Latest

-

Triple Flag Delivers Record Earnings Per Share and Operating Cash Flow Per Share Growth in 2025

TORONTO--(BUSINESS WIRE)--Triple Flag Precious Metals Corp. (with its subsidiaries, “Triple Flag” or the “Company”) (TSX: TFPM, NYSE: TFPM) announced its results for the fourth quarter and full year of 2025 and declared a dividend of US$0.0575 per common share to be paid on March 16, 2026. All amounts are expressed in US dollars, unless otherwise indicated. “2025 marked another milestone year for Triple Flag, as we continued to build on our track record of delivering record GEOs performance, hi...
-

Oceaneering Reports Fourth Quarter and Full Year 2025 Results

HOUSTON--(BUSINESS WIRE)--Oceaneering Reports Fourth Quarter and Full Year 2025 Results...
-

Triple Flag Declares Q1 2026 Dividend

TORONTO--(BUSINESS WIRE)--Triple Flag Precious Metals Corp. (with its subsidiaries, “Triple Flag” or the “Company”) (TSX: TFPM, NYSE: TFPM) is pleased to announce that its Board of Directors has approved the declaration of a cash dividend of US$0.0575 per common share to be paid on March 16, 2026, to the shareholders of record at the close of business on March 2, 2026. About Triple Flag Precious Metals Corp. Triple Flag is a precious metals streaming and royalty company. We offer investors expo...
-

Aptar to Participate in Upcoming Investor Conferences

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar to Participate in Upcoming Investor Conferences...
-

SS&C Seamlessly Transitions REI Super’s Member Administration

WINDSOR, Conn.--(BUSINESS WIRE)--SS&C Seamlessly Transitions REI Super’s Member Administration...
-

ViiV Healthcare’s long-acting Cabenuva (cabotegravir + rilpivirine) for HIV demonstrates superior efficacy compared to daily oral therapy for people with adherence challenges; results published in NEJM

LONDON--(BUSINESS WIRE)--ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced final data from the LATITUDE phase III trial, confirming its long-acting injectable treatment for HIV, Cabenuva (cabotegravir + rilpivirine), demonstrated superior efficacy in maintaining viral load suppression compared to daily oral therapy in individuals with a history of antiretroviral treatment (ART) adherence challenges.1 The 48-week...
-

Ferguson Declares Dividend

NEWPORT NEWS, Va.--(BUSINESS WIRE)--On February 18, 2026, the Ferguson Enterprises Inc. (NYSE: FERG; LSE: FERG) board of directors declared a dividend of $0.89 per share. The timetable for payment of the dividend is as follows: Ex-dividend date: March 6, 2026 Record date: March 6, 2026 Currency election deadline for Depositary Interest holders: April 1, 2026 Payment date: April 30, 2026 The completion of cross-border movements of shares between the U.K. and the U.S. is contingent upon the recei...
-

Liberty Latin America Reports Q4 and FY 2025 Results

DENVER, Colorado--(BUSINESS WIRE)--Liberty Latin America Ltd. ("Liberty Latin America" or "LLA") (NASDAQ: LILA and LILAK, OTC Link: LILAB) today announced its financial and operating results for the three months ("Q4") and full year ("FY") ended December 31, 2025. CEO Balan Nair commented, "The fourth quarter capped a strong year of commercial momentum across the Liberty Latin America group." "The residential mobile business maintained its cadence of strong postpaid mobile subscriber additions...
-

Securities Fraud Investigation Into HF Sinclair Corporation (DINO) Announced – Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of HF Sinclair Corporation (“HF Sinclair” or the “Company”) (NYSE: DINO) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON HF SINCLAIR CORPORATION (DINO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What H...
-

CVR Partners Files Form 10-K Annual Report For Fiscal Year Ended December 31, 2025

SUGAR LAND, Texas--(BUSINESS WIRE)--CVR Partners, LP (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (“UAN”) solution fertilizer products, announced that its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, was filed today with the Securities and Exchange Commission and can be viewed on its website at www.CVRPartners.com by selecting the “SEC Filings” link. Upon written request, unitholders may receive, free of charge, a printed copy of the Annual Report...